Status:

COMPLETED

Efficacy, Safety and Tolerability of Split-dose of PEG Compared With NaP Solution for Colonoscopy Preparation: A Randomized, Controlled Trial

Lead Sponsor:

Inje University

Conditions:

Bowel Preparation, Efficacy, Tolerability, Safety

Eligibility:

All Genders

18-64 years

Phase:

PHASE3

Brief Summary

: In several studies comparing of sodium phosphate solutions versus PEG, both regimen had similar efficacy of bowel cleansing and sodium phosphate solutions are more acceptable to patients because pat...

Detailed Description

Study design: Investigator-blinded, prospective, randomized controlled trial Subjects 1. Entry criteria: Adult outpatients(at least 18 years of age, under 65 years) who undergo scheduled colonoscopy...

Eligibility Criteria

Inclusion

  • Adult outpatients(at least 18 years of age, under 65 years) who undergo scheduled colonoscopy for screening, cancer surveillance or want procedure with/without non-specific gastrointestinal symptoms

Exclusion

  • age under 18 years, elderly patients(\>,=65 yrs), pregnancy, breast feeding, patient with bowel obstruction, and other structural intestinal disorders, gut hypomotility(chronic constipation(\< 2 bowel movement/week for 1yr), hypomotility syndrome, megacolon, idiopathic pseudoobstruction), renal failure, congestive heart failure, liver failure, pre-existing electrolyte disturbance(hypercalcemia, hyperphosphatemia); refusal of consent to participate in the study.

Key Trial Info

Start Date :

August 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2010

Estimated Enrollment :

207 Patients enrolled

Trial Details

Trial ID

NCT01229800

Start Date

August 1 2010

End Date

October 1 2010

Last Update

October 28 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Inje University School of Medicine, Haeundae Paik Hospital

Busan, South Korea, 612-030